WADDELL & REED FINANCIAL INC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 7 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WADDELL & REED FINANCIAL INC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2017$2,271,000
+3.5%
25,0000.0%0.01%0.0%
Q1 2017$2,195,00025,0000.01%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2017
NameSharesValueWeighting ↓
Maven Securities LTD 38,500$2,907,0000.13%
BOOTHBAY FUND MANAGEMENT, LLC 75$566,0000.02%
GROUP ONE TRADING, L.P. 150,100$11,334,0000.02%
SIMPLEX TRADING, LLC 752$5,678,0000.01%
IMC-Chicago, LLC 57,700$4,357,0000.01%
Worth Venture Partners, LLC 4,500$13,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 43,400$3,277,0000.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders